2 in 1 protection against canine influenza which facilitates vaccination protocols
Reduces the incidence and severity of coughing86
Decreases the overall clinical signs of disease, including ocular and nasal discharge, coughing, sneezing, depression, and dyspnea86
Demonstrates protection against the formation and severity of lung lesions86
Contains inactivated virus. Adjuvanted to enhance immune response
This product has been shown to be effective for vaccination of healthy dogs 7 weeks of age or older against canine influenza virus.
CANINE FLU BIVALENT IS A SAFE CHOICE
Safety confirmed through clinical use1
Well tolerated on subcutaneous administration
Proven safe across a multitude of dog breeds and ages
Nobivac® Canine Flu Bivalent was shown to be 99.1% reaction-free in the field safety trial1
ADMINISTRATION AND DOSAGE
1 mL subcutaneous injection
Booster two to four weeks later
Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. Contact your veterinarian or manufacturer for more information on revaccination frequency.